Kennedy Removes Key Vaccine Advisors | US Health News
Health Secretary Kennedy has dismissed the CDC’s vaccine advisory panel, immediately sparking controversy. This bold move, replacing all 17 members, raises serious questions about potential political influence on vaccine policy and threatens to undermine public trust in established health guidelines. Experts fear the overhaul could weaken confidence in crucial primary_keyword like vaccine recommendations and guidelines, a move that already has ripples. In a further twist, analysts note dips in vaccine maker stocks, reflecting market anxieties secondary_keyword. This story is developing, and News Directory 3 is following the fallout. Discover what’s next as the revamped advisory group is set to meet.
Health Secretary Kennedy Fires vaccine Experts, Sparks Controversy
Updated June 10, 2025
Washington—Health and Human Services Secretary Robert F. Kennedy Jr. has dismissed all 17 members of the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), his department announced Monday. The action, which involves replacing the entire panel of vaccine experts, has drawn criticism from vaccine scientists and public health officials.
Kennedy,a long-time vaccine skeptic,pledged to maintain existing vaccine standards when appointed. Though, this move is seen as the most meaningful in a series of actions to reshape U.S. regulation of vaccines, food, and medicine. Experts fear the changes to the ACIP,which advises the CDC on vaccine use,could erode public confidence in health agencies and established vaccine policy.
Kennedy defended the decision, stating his priority is “restoration of public trust above any specific pro- or anti-vaccine agenda,” according to a statement from HHS.
Despite concerns, the Food and Drug governance (FDA), overseen by Kennedy’s department, has approved several vaccines during his tenure. Even so, some members of Congress have voiced concerns about the panel’s overhaul.
Kennedy contends that the ACIP is plagued by conflicts of interest and has never rejected a vaccine. He emphasized that while the FDA approves vaccines, the CDC panel offers guidance on which populations benefit most from approved vaccines. This vaccine guidance is crucial for public health planning.
“That’s a tragedy. This is a highly professional group of scientists and physicians and others… It’s the kind of political meddling that will reduce confidence rather than increase confidence,” said former FDA Chief Scientist Jesse Goodman.
The Pharmaceutical Research and Manufacturers of America (PhRMA) also expressed concern, stating, “Upending the ACIP membership increases uncertainty and vaccine skepticism, undermining the health gains achieved through vaccination.”
Following the announcement, shares of vaccine manufacturers Moderna and BioNTech experienced declines of more than 1%, while Pfizer shares also dipped slightly in extended trading.
While Kennedy asserted that many panel members receive funding from drugmakers, he and HHS provided no specific evidence of conflicts of interest among the departing ACIP members. CDC records indicate that one member had previously recused herself from votes on certain vaccines due to prior work on clinical trials for their manufacturers.
HHS noted that all 17 ACIP members where appointed during the previous administration, including 13 in 2024. Without their removal, the current administration would not have been able to appoint a majority of the committee until 2028.
“This is not a political committee, it’s never been partisan,” said Dorit Reiss, a vaccine law expert at UC Law San Francisco. “It’s an expert committee. Presidents have never been involved in ACIP membership.”
Sen. Bill Cassidy, R-La., said he spoke with Kennedy to ensure the ACIP is not filled with individuals who are merely suspicious of vaccines. Cassidy had previously secured assurances from Kennedy that existing vaccination programs would be protected.
The CDC panel is scheduled to convene its next meeting June 25-27 in Atlanta. One expert with close ties to the committee expressed doubt that the newly appointed panel would be ready to meet on time, unless preparations had been underway for months.
Kennedy has faced criticism for his vaccine policies, including his stance on measles vaccinations during a recent outbreak. Last month, he announced the government was dropping its recommendation for COVID shots for healthy children and pregnant women, bypassing the standard review process.
Traditionally, after FDA approval, the ACIP reviews data in a public forum and votes on vaccine recommendations, which are then sent to the CDC director for approval.These recommendations influence insurance coverage and the CDC’s Vaccines for Children program.
What’s next
The revamped ACIP will face immediate pressure to address ongoing public health challenges and maintain confidence in vaccination programs. The selection and vetting process for new members will be closely watched by both public health experts and the pharmaceutical industry.